Tata Motors tops with Rs 4,224.6 cr, or 1.4% of its net sales. A lot of it is due to JLR
Lower expenditure by pharmaceutical companies may be a key reason for the fall
The growth in R&D expenditure should be commensurate with the economy's growth and should be targeted to reach at least 2 per cent of the GDP by 2022, according to the Economic Advisory Council to the Prime Minister (EAC-PM). In a report titled 'R&D Expenditure Ecosystem', the EAC-PM said that the line ministries at the Centre could be mandated to allocate certain percentage of their budget for research and innovation for developing and deploying technologies as per the priorities of the respective ministries. "The growth in R&D expenditure should be commensurate with the growth of GDP and should be targeted to reach at least 2 per cent of GDP by 2022," the report said. It pointed out that India's public investment in R&D as a fraction of GDP has remained stagnant over the last two decades. It has remained constant at around 0.6 per cent to 0.7 per cent of GDP and this is well below the major countries such as the US (2.8 per cent), China (2.1 per cent), Israel (4.3 ...
Multiple factors have driven the increase in R&D spending
Low single-digit growth for the biggest of Indian companies
As much as 81.3% of R&D expenditure incurred by central government sources came from just eight major scientific agencies